Aurobindo Pharma Arm Apitoria Pharma CEO Dr Sanjay Chaturvedi Resigns
New Delhi: Aurobindo Pharma Limited has announced the resignation of Dr Sanjay Chaturvedi as Chief Executive Officer of its wholly owned subsidiary, Apitoria Pharma Private Limited, effective May 4, 2026, as he moves on to pursue another opportunity.
According to the company’s official communication dated May 4, 2026, Dr Sanjay Chaturvedi has stepped down from his role as CEO of Apitoria Pharma Private Limited. The resignation has been accepted, and he has been relieved from his duties with effect from the close of business hours on the same day.
The company clarified that the reason for his resignation is his decision to move on to a different opportunity. Apitoria Pharma Private Limited is a wholly owned subsidiary of Aurobindo Pharma Limited.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.